Narrow Band Imaging Bronchoscopy During SARS-CoV2 Infection
- Conditions
- Narrow-band ImagingBronchoscopyCovid19
- Interventions
- Other: NBI images and/or videos
- Registration Number
- NCT04884061
- Lead Sponsor
- Centre Hospitalier Universitaire, Amiens
- Brief Summary
Vascular modifications have been described during SARS-CoV2 infection, especially a dilatation of the bronchial arteries. Within the airway wall, small branches of the bronchial arteries cross the muscle layer to develop a submucosal network. The Narrow Band Imaging technique is used during bronchoscopy to achieve a maximum contrast of vessels and the surrounding mucosa. Therefore, it enables to observe the microvessel structure and its distribution in the bronchial mucosa. The aim of this study is to describe the vasculature pattern of the bronchial tree during infection with SARS-CoV2.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 27
- Patients who undergo bronchoscopy with image and/or videos recording of NBI aspect of the proximal bronchial tree (carina, right and left upper lobe).
- Patients hospitalized with SARS-CoV2 infection proven by RT-PCR test
- patients hospitalized with lower respiratory tract infections unrelated to SARS-CoV2 (RT-PCR negative for SARS-CoV2)
- Patients who have had bronchoscopy performed as part of the assessment of a distal pulmonary nodule (RT-PCR negative for SARS-CoV2).
- Patients under legal protection
- Patients who refuses the use of his personal medical data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Experimental NBI images and/or videos Patients hospitalized with SARS-CoV2 infection proven by RT-PCR test Comparator 2 NBI images and/or videos Patients who have had bronchoscopy performed as part of the assessment of a distal pulmonary nodule (RT-PCR negative for SARS-CoV2). Comparator NBI images and/or videos Patients hospitalized with lower respiratory tract infections unrelated to SARS-CoV2 (RT-PCR negative for SARS-CoV2)
- Primary Outcome Measures
Name Time Method Variation of the vasculature pattern of the bronchial mucosa between the three patient groups 2 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU Amiens
🇫🇷Amiens, France